UnitedHealth Group Incorporated (NYSE:UNH) is DAVENPORT & Co LLC’s 10th Largest Position

01 Jul 2025, 13:36 by Renee Jackson · The Cerbat Gem

DAVENPORT & Co LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 442,716 shares of the healthcare conglomerate’s stock after purchasing an additional 22,936 shares during the quarter. UnitedHealth Group comprises about 1.3% of DAVENPORT & Co LLC’s investment portfolio, making the stock its 10th biggest position. DAVENPORT & Co LLC’s holdings in UnitedHealth Group were worth $231,240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Geode Capital Management LLC grew its holdings in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the period. Norges Bank bought a new position in UnitedHealth Group in the 4th quarter worth approximately $6,375,744,000. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after buying an additional 861,854 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.9%

Shares of UnitedHealth Group stock opened at $311.89 on Tuesday. The firm has a market capitalization of $282.93 billion, a PE ratio of 13.06, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The company’s fifty day moving average price is $333.94 and its two-hundred day moving average price is $452.07. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the prior year, the company earned $6.91 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.83%. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other news, CFO John F. Rex acquired 17,175 shares of the company’s stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares of the company’s stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Company insiders own 0.28% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on UNH. KeyCorp lowered their price target on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Robert W. Baird lowered shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. Truist Financial reissued a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $415.57.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.